Risultati della ricerca

• 1. AISF – Fegato grasso, colpito il 25% della popolazione. Più a rischio obesi e diabetici. Nuovi studi italiani migliorano prevenzione, diagnosi e follow up (100%)

  27-mar-2023 9.20.56

  AISF – Fegato grasso, colpito il 25% della popolazione. Più a rischio obesi e diabetici. Nuovi studi italiani migliorano prevenzione, diagnosi e follow up articolo, notizia, unipa, aisf, Fegato grasso, obesi, diabetici, NAFLD, Non Alcoholic Fatty Liver Disease, Steatosi epatica non alcolica, Vincenza Calvaruso, intervista, terza missione, public_engagement, Dall’Università di Palermo uno studio conferma l’Elastografia epatica tramite Fibroscan® come strumento migliore per accuratezza

• 2. CV_modello_europeo_CAMMA con pubblicazioni 12 2019 (85%)

  9-mar-2021 18.51.36

  Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease. Clin ... platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol. 2018 Oct;69(4):878-885. doi: 10.1016 ... of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study ... in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2017 Feb;45(4):510-518 ... Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One. 2015 Dec 16;10

• 3. CV Ciro Celsa ITA (74%)

  26-feb-2020 10.14.44

  rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease ... -Related Outcomes in Patients with Non-Alcoholic Fatty Liver Disease. Available at SSRN 3347913. 2019 ... A, et al. P162 Prevalence of nafld (non alcoholic fatty liver disease) and fibrosis in inflammatory ... , Giammanco A, Spatola F, Petta S. The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver ... Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives. Int J Environ Res Public

• 4. cv licata (64%)

  20-ott-2022 12.17.03

  with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease. PLoS One ... with Non-alcoholic Fatty Liver Disease. AP&T submitted Aliment Pharmacol Ther. 2017 Feb;45(4):510-518 ... Induced Liver Injury (DILI) and Non-Alcoholic Fatty Liver Disease (NAFLD). Eur J of Med Health Sci 2 ... on the outcome of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2022 Mar 27;23(7):3668. doi: 10.3390 ... -alcoholic fatty liver disease (NAFLD): a case control study. Cardiovasc Diabetol. 2018 Feb 16;17(1):28. doi

• 5. cv_portincasa (63%)

  11-mar-2021 11.39.33

  in the Pathophysiology and Treatment of Non- Alcoholic Fatty Liver Disease — Foie Gras - EU-Horizon 2020 Grant 722619 ... ) 2015. 3. Portincasa P. Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease — Foie Gras - EU-Horizon 2020 Grant 722619, 2017. 4. Portincasa P

• 6. malaguarnera_lucia_ (49%)

  22-apr-2020 14.50.28

  oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol ... , Malaguarnera L. Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease. Hepatol Res. 2013;43:267-75 40. Malaguarnera M, Cristaldi E, Romano G, Malaguarnera L ... M. Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut. 2006;55:1313-20 62. Vicari L, Eramo A, Manzella L, Malaguarnera L, Iannolo G

• 7. cv nicoletti (41%)

  16-gen-2018 14.47.25

  Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease

• 8. cv prof. edoardo g giannini (41%)

  15-apr-2022 13.30.38

• 9. cv_galvano (40%)

  11-mar-2021 11.39.31

  ) Rosuvastatin reduces non alcoholic fatty liver disease in patients with chronic hepatitis C ... intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. JHEP Rep. 2020 Jan 28;2(2):100069. doi: 10.1016/j.jhepr.2020.100069. 2. Grosso G

• 10. 2014_2722_bando craxì med 12 (40%)

  18-lug-2014 13.54.26

  significant fibrosis in patients with non-alcoholic fatty liver disease - Descrizione ... invasivi. - Description: Non-alcoholic fatty liver disease (NAFLD) is the hepatic expression

• 11. 5363300 bando_prin2022_prof. petta_en (40%)

  19-mar-2024 9.27.36

  medicine to stratify disease severity and outcomes of patients with non- alcoholic fatty liver disease ... : Precision medicine to stratify disease severity and outcomes of patients with non-alcoholic fatty liver disease by using artificial Intelligence, to be carried out at the Department of Health

• 12. cv prof. rezzani (33%)

  31-mag-2022 11.39.49

  ., Rodella L.F., Rezzani R. Critical role of NFκB in the pathogenesis of non-alcoholic fatty liver disease

• 13. medicina del benessere, nutrogenomica e malattie degenerative (33%)

  25-lug-2017 12.19.00

  (Non Alcoholic Fatty Liver Disease) (NAFLD) is defined by the presence of a wide spectrum

• 14. BIND - Documento Allegato a Riesame 2019 (33%)

  7-ott-2020 10.47.54

  in attesa liver fibrosis in Non Alcoholic Fatty Liver Disease by serum markers, FibroScan, MR

• 15. Locandina Gastro-Day 2019 (33%)

  12-nov-2019 16.13.25

  : Outcome clinici nei pazienti con colangite biliare primitiva Ore 10.20 Barbara Scrivo: La NAFLD (Non Alcoholic Fatty Liver Disease) nelle malattie infiammatorie croni- che intestinali: analisi dei fattori

• 16. medicina-del-benessere-nutrogenomica-e-malattie-degenerativeXXXIII ciclo (33%)

  19-giu-2017 14.04.25

  (Non Alcoholic Fatty Liver Disease) (NAFLD) is defined by the presence of a wide spectrum

• 17. curriculum vitae, dichiarazioni e documento prof. c. vecchione (28%)

  15-apr-2020 8.24.51

  M, Federico A, Rosato V, Bucci T, Carrizzo A, Vecchione C. "Non alcoholic fatty liver disease

• 18. cv rodella (28%)

  10-lug-2018 10.08.25

  to microsteatosis by melatonin supplementation in ob/ob mice non-alcoholic fatty liver disease

• 19. MdG Newsletter luglio 2021 (28%)

  8-set-2021 13.54.56

  of sexual dimorphism in non- alcoholic fatty liver disease (NAFLD) and non- Int J Mol Sci. 2021; 22

• 20. Albo Dottori XXIV ciclo Anno 2014 (28%)

  24-giu-2021 9.52.29

  ALTIERI GRAZIA IDA PALERMO PA 29/12/1985 SFINGO-LIPIDOMICA DELLA NON ALCOHOLIC FATTY LIVER DISEASE